CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 160 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488,645 | -54.1% | 17,756 | -43.4% | 0.00% | -33.3% |
| Q2 2023 | $1,064,214 | +47.0% | 31,365 | +55.9% | 0.00% | 0.0% |
| Q1 2023 | $724,062 | +131.8% | 20,124 | +187.2% | 0.00% | +200.0% |
| Q4 2022 | $312,347 | -19.5% | 7,008 | -49.2% | 0.00% | 0.0% |
| Q3 2022 | $388,000 | -49.2% | 13,789 | -51.3% | 0.00% | 0.0% |
| Q2 2022 | $764,000 | +13.4% | 28,320 | +43.2% | 0.00% | 0.0% |
| Q1 2022 | $674,000 | -61.4% | 19,776 | -56.3% | 0.00% | 0.0% |
| Q4 2021 | $1,747,000 | +18.8% | 45,208 | +65.9% | 0.00% | -50.0% |
| Q3 2021 | $1,471,000 | +67.3% | 27,251 | +3.7% | 0.00% | +100.0% |
| Q2 2021 | $879,000 | -48.4% | 26,283 | -68.2% | 0.00% | -66.7% |
| Q1 2021 | $1,702,000 | +302.4% | 82,637 | +242.1% | 0.00% | +200.0% |
| Q4 2020 | $423,000 | +2388.2% | 24,159 | +140.0% | 0.00% | – |
| Q1 2020 | $17,000 | -29.2% | 10,065 | -7.4% | 0.00% | – |
| Q4 2019 | $24,000 | -36.8% | 10,870 | -39.1% | 0.00% | – |
| Q3 2019 | $38,000 | +100.0% | 17,837 | +157.1% | 0.00% | – |
| Q2 2019 | $19,000 | -64.8% | 6,937 | -36.6% | 0.00% | -100.0% |
| Q1 2019 | $54,000 | – | 10,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |